Introduction to the Fortrea Class Action Lawsuit
The news of the Fortrea Class Action Lawsuit shocked the investment community after the stock price plummeted 25.1% on March 3, 2025. Our team has tracked this case closely as investors launched a class action against Fortrea Holdings, Inc. (NASDAQ: FTRE). The Fortrea Class Action Lawsuit claims the company misled investors about its business and financial outlook.
The Fortrea Lawsuit lawsuit points to Fortrea’s overstatement of revenue from Pre-Spin Projects and inflated EBITDA targets for 2025. The company’s full-year adjusted EBITDA for 2024 reached only $202.50 million, which fell below their guidance of $220.00 to $240.00 million. The stock had already taken hits before this major drop. Jefferies’ downgrade from buy to hold caused a 12.3% drop, and Baird Equity Research’s change from outperform to neutral led to an 8.1% decline.
The U.S. District Court for the Southern District of New York now handles this case. The Fortrea Lawsuit alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Investors affected during the class period from July 3, 2023, to February 28, 2025, have until August 1, 2025, to step forward as lead plaintiff in this ongoing legal battle.
Investors File Class Action Lawsuit Against Fortrea

Investors have filed a class action lawsuit against Fortrea Holdings Inc. after seeing their portfolios decimated which they blame on the company and its executives. This marks one of the most important legal challenges for the clinical research organization. The Fortrea Lawsuit claims securities fraud and aims to represent investors who bought or acquired Fortrea securities during a specific period.
Lawsuit filed in Southern District of New York
The United States District Court for the Southern District of New York now has a major securities class action lawsuit against Fortrea Holdings and its top executives. The case is officially known as Deslande v. Fortrea Holdings Inc., No. 25-cv-04630. It charges the company with violations of federal securities laws.
The legal claims point to violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. These sections stop companies from making false statements or leaving out key information that investors need to make decisions about buying securities.
Court documents show that Fortrea allegedly made misleading statements. The company overstated revenue from pre-spin projects and exaggerated cost savings from ending transition services agreements with Labcorp. They also inflated 2025 EBITDA targets to paint a better picture of the company’s post-spin success.
Class period spans July 3, 2023 to February 28, 2025

The class action lawsuit covers people who bought Fortrea securities between July 3, 2023 and February 28, 2025. This “Class Period” started right after Labcorp Holdings Inc. spun off Fortrea into a standalone, public company in June 2023.
Investors might have bought securities based on what they now claim were false or misleading company statements. The Fortrea Class Action Lawsuit wants to get money back for these investors who lost funds due to the company’s alleged misrepresentations.
The court picked August 1, 2025 as the deadline for affected investors to ask for Lead Plaintiff appointment. This date falls on the first business day after 60 days from when the action notice was published.
Investors have two main choices in this lawsuit:
- Seek Lead Plaintiff Status: Investors can file motions by August 1 to become lead plaintiffs. This gives them more control over outcomes but adds responsibility
- Join as Class Members: Anyone who purchased FTRE during the Class Period and suffered a loss automatically becomes a class member. They still need to register by the deadline to get any potential recovery
This legal process is a great way to get damages without paying legal fees upfront. The law firms handling the case say investors must act quickly within the given timeframe to protect their interests.
The lawsuit comes at a tough time for Fortrea. The company’s stock price has been quite volatile lately. Legal teams want to find out if the company’s statements during the Class Period made sense or if they misled investors about revenue projections, cost savings estimates, and financial targets that didn’t work out as promised.
Fortrea Allegedly Misleads Investors on Financial Outlook
The Fortrea Class Action Lawsuit focuses on three areas where the company might have misled investors about its financial future after splitting from Labcorp in 2023. These claims suggest the company painted an unrealistic picture of how well it would do on its own.
Revenue from pre-spin projects overestimated
The lawsuit’s main focus points to Fortrea’s high estimates of revenue from “Pre-Spin Projects” – the long-term contracts they got from Labcorp before breaking away in June 2023. Court documents show these projects were already winding down and would bring in “less revenue and less profitability than expected for 2025”.
The truth came out during Fortrea’s March 3, 2025, earnings call. The company admitted these inherited projects weren’t doing as well as they’d said. On top of that, executives had to acknowledge that “post-spin work is not coming on fast enough to offset the pre-spin contract economics”.
The Fortrea Lawsuit claims Fortrea’s leaders knew about these revenue problems but kept making positive predictions anyway. The complaint points out that the “older versus newer mix issue will continue to negatively impact [Fortrea’s] financial performance during 2025“. This mix of old and new projects created a big problem in the company’s financial forecasts that leaders didn’t tell investors about.
Cost savings from TSA exits exaggerated
Another big claim targets Fortrea’s statements about saving money by ending their Transition Service Agreements (TSAs) with Labcorp. The company first presented these exits as a way to improve profit margins.

Investment bank Jefferies dropped some bad news on September 25, 2024. They said the TSA cost savings were “[n]ot as [m]aterial as [o]ne [m]ight [t]hink”. The stock fell 12.3% to USD 19.48 after this report.
The Fortrea Lawsuit explains a key problem with how these savings were presented: “IT infrastructure costs to exit the TSAs are already non-GAAPed out of adjusted EBITDA. Thus, once TSAs are exited, [Fortrea] will just be replacing TSA costs with internal operating costs”. This means the company was just moving costs around rather than cutting them.
EBITDA targets for 2025 allegedly inflated
The lawsuit’s biggest claim says Fortrea’s EBITDA targets for 2025 were too high because they used inflated revenue estimates and overstated cost savings.
Fortrea started by predicting 2025 adjusted EBITDA margins around 13%. They later dropped this to “11% to 12%” but still promised “a 30% to 40% increase in adjusted EBITDA dollars delivered”.
Things turned out much worse. By March 2025, Fortrea cut its guidance to 2025 revenue between USD 2.45-USD 2.55 billion and adjusted EBITDA of USD 170.00-USD 200.00 million. This big drop supports claims that their earlier numbers weren’t realistic.
The company’s 2024 results back up these concerns. Their full-year adjusted EBITDA hit only USD 202.50 million, missing their target of USD 220.00 to USD 240.00 million. This miss made investors even more worried about the company’s predictions and business model.
The Fortrea Class Action Lawsuit claims these issues broke federal securities laws through “materially false and/or misleading statements“. The complaint says Fortrea “failed to disclose material adverse facts about the Company’s business, operations, and prospects“, which led investors to buy shares at artificially high prices.
Stock Price Plunges After Analyst Downgrades and Earnings Miss
Fortrea’s stock price saw three major downward movements between September 2024 and March 2025. These dramatic price drops are the foundations of the Fortrea Class Action Lawsuit. Investors claim the company knowingly misled them about its financial outlook.
Jefferies downgrade triggers 12% drop
Investment bank Jefferies gave a devastating assessment of Fortrea’s prospects on September 25, 2024. They downgraded the stock from “buy” to “hold”. Their report noticed weaknesses in Fortrea’s business model as a Contract Research Organization (CRO), especially when you have pressure on biotechnology funding.

Jefferies directly challenged Fortrea’s claims about cost savings from exiting Transition Service Agreements (TSAs). They stated these savings were “[n]ot as [m]aterial as [o]ne [m]ight [t]hink”. The analysts explained: “IT infrastructure costs to exit the TSAs are already non-GAAPed out of adjusted EBITDA. Thus, once TSAs are exited, [Fortrea] will just be replacing TSA costs with internal operating costs”.
The market reacted immediately to this downgrade. Fortrea’s stock price dropped 12.29% in a single trading day. It fell from $22.21 per share on September 24 to close at $19.48 on September 25, 2024. This was the first major stock decline cited in the class action lawsuit.
Baird downgrade follows canceled conferences
The second big drop came on December 6, 2024. Baird Equity Research, another respected market analyst, downgraded Fortrea from “outperform” to “neutral”. This came after Fortrea suddenly canceled two scheduled investor conferences and a planned non-deal roadshow.
Baird cut its price target for Fortrea from $28.00 to $25.00. They cited ongoing sector concerns and what they called Fortrea’s “choppy history post spin”. The report specifically mentioned the company’s sudden communication changes as a key reason for their cautious stance.
The analyst didn’t mince words: “Given our ongoing concerns around the sector, [Fortrea’s] choppy history post spin, and lack of clarity on the abrupt communications course change, we cannot recommend an actionable investment (buy or sell)”. The downgrade, combined with speculation about “perhaps there is a takeout looming, perhaps there is bad news looming,” sent Fortrea shares down 8.06% to close at $21.67.
March 2025 earnings call leads to 25% crash
The strongest evidence in the Fortrea Lawsuit emerged on March 3, 2025. The company announced its fourth quarter and full year 2024 financial results. These results showed substantial shortfalls compared to previous guidance.
Fortrea revealed that its “targeted revenue and adjusted EBITDA trajectories for 2025 [were] not in line with [its] prior expectations”. Executives admitted during the earnings call that Pre-Spin projects were “late in their life cycle [and] have less revenue and less profitability than expected for 2025”. They also acknowledged that “post-spin work is not coming on fast enough to offset the pre-spin contract economics”.
Fortrea’s full-year adjusted EBITDA reached only $202.50 million, nowhere near their previously guided range of $220.00 to $240.00 million. The company provided much lower 2025 guidance:
- Revenue of $2.45 billion to $2.55 billion
- Adjusted EBITDA of just $170.00 million to $200.00 million
This reset of expectations sent Fortrea’s stock crashing. Shares fell 25.05% in a single trading day, dropping from $13.85 per share on February 28 to $10.38 on March 3, 2025. The stock dropped another 12.27% to $6.15 in pre-market trading after the first quarter earnings call, moving closer to its 52-week low of $4.77.
These three major stock drops—with over 45% in total losses—now serve as key evidence in the Fortrea Class Action Lawsuit. The lawsuit claims the company made false and misleading statements about its business prospects and financial outlook.
Executives Named in Fortrea Lawsuit Face Scrutiny
Fortrea Holdings Inc.’s senior leadership faces serious legal accusations. The Fortrea Class Action Lawsuit targets both the company and its top executives as defendants. These leaders allegedly misled investors about the company’s financial health and prospects after its 2023 spin-off from Labcorp.
Top management accused of withholding key information
The Fortrea Lawsuit. charges “Fortrea Holdings Inc. and certain of the Company’s senior executives” with federal securities law violations. The core team allegedly withheld critical information from investors and the public during the Class Period from July 3, 2023, to February 28, 2025.
Primary allegations against management include:
- Concealing revenue shortfalls – Executives knew but didn’t disclose that pre-spin projects “have less revenue and less profitability than expected for 2025”
- Misrepresenting TSA exit benefits – Management painted transition service agreement exits as major cost-saving opportunities while knowing internal costs would offset the savings
- Withholding information about business model viability – Leadership hid that “post-spin work is not coming on fast enough to offset the pre-spin contract economics”

Legal claims point to violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Section 10(b) bans manipulative and deceptive practices in securities trading. Section 20(a) holds controlling persons liable who knowingly take part in securities fraud.
The lawsuit zeros in on executive statements during investor calls, conferences, and public disclosures. Leaders repeatedly highlighted the company’s “commercial transformation” and claimed it was “already delivering results, most visibly in terms of new business”. The legal complaint suggests management knew these statements had no factual backing.
Statements allegedly lacked reasonable basis
The Fortrea Lawsuit claims executives made unsupported statements about three critical financial aspects.
Executives made claims about 2025 earnings from pre-spin projects that “lacked reasonable basis”. Management should have known aging Labcorp-era contracts were declining faster than they admitted publicly.
Statements about cost savings from Labcorp transition service agreement exits also “lacked reasonable basis“. Jefferies later noted many “IT infrastructure costs to exit the TSAs are already non-GAAPed out of adjusted EBITDA.” This meant Fortrea “will just be replacing TSA costs with internal operating costs”.
Executives kept making unsupported statements about 2025 EBITDA targets during the Class Period. They first projected 2025 EBITDA margins around 13% and later revised to “11% to 12%.” Management allegedly knew these targets were impossible given the real state of pre-spin contracts and post-spin business growth.
The Fortrea Lawsuit states that “Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects”. Federal securities law creates potential personal liability for executives who knew about or participated in the alleged fraud.
The court will now determine if Fortrea’s leadership made legitimate business projections or crossed into misleading territory. Their statements could have harmed investors who based investment decisions on these representations.
How Investors Can Join the Fortrea Lawsuit
Shareholders who lost money on Fortrea Holdings Inc. can now take legal action through a class action lawsuit. Several law firms want investors to join the legal case against this clinical research organization.
Eligibility criteria for class members
The Fortrea Class Action Lawsuit covers people who bought or acquired Fortrea securities between July 3, 2023, and February 28, 2025. This applies to anyone who purchased shares during this time and lost money after the stock price went down.
Investors can participate in two ways:
- Lead plaintiff role: Represents the class and guides litigation strategy
- Regular class member: Gets included with potential recovery rights

You don’t need to act right away to stay in the class. One law firm states: “To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action”.
Shareholders who experienced big losses and want to serve as lead plaintiff, or just want to learn about their rights, can contact attorney Timothy L. Miles at the Law Offices of Timothy L. Miles. He offers free consultations at 855/846-6529 or via e-mail at [email protected].
Deadline to file as lead plaintiff: August 1, 2025
Federal securities laws set strict timelines that investors must watch. Court documents show August 1, 2025 as the last day to ask for appointment as lead plaintiff in the Fortrea Class Action Lawsuit .
The lead plaintiff speaks for all class members and shapes the lawsuit’s direction. This position usually goes to investors who lost the most money and want to actively participate.
Missing this deadline could affect your rights. The Securities and Exchange Act lets any investor who bought Fortrea securities during the Class Period become lead plaintiff.
No upfront legal fees for participants
The best part about joining the Fortrea Lawsuit is that there’s no financial risk. Law firms take these securities cases on a contingency fee basis.
Legal notices make this clear: “All representation is on a contingency fee basis. Shareholders pay no fees or expenses”. You won’t have to cover any court costs or lawsuit expenses.
If the case wins or settles, lawyers ask the court to approve their fees and expenses as a percentage of the recovery amount. This setup helps investors seek compensation without worrying about money upfront.
What This Lawsuit Means for Corporate Transparency
The Fortrea Class Action Lawsuit lights up broader concerns about corporate transparency, especially for companies that just became independent after spin-offs. This case teaches investors valuable lessons and explains the most important gaps in how spin-off companies share their financial projections.
Spinoff structures and investor risk
The Fortrea case reveals basic weaknesses in corporate spin-off structures. Spin-offs face immediate pressure to prove they can survive on their own, unlike traditional IPOs. Fortrea signed multiple Transition Service Agreements (TSAs) with its former parent Labcorp after separating in June 2023. These arrangements made it hard for investors to tell the difference between short-term and long-term costs.
The lawsuit teaches us a crucial lesson about pre-spin projects. These aging contracts—”late in their life cycle”—brought in nowhere near the revenue projected for 2025. The company also stated that “post-spin work is not coming on fast enough to offset the pre-spin contract economics”. Investors weren’t told enough about what this timing gap meant for their risk.
Investors must do these things for future spin-offs, particularly in specialized sectors like contract research organizations:
- Question revenue projections tied to legacy contracts
- Verify the true costs behind transition service exits
- Just need clearer timelines on post-separation business development
Legal obligations under Securities Exchange Act

The Fortrea Lawsuit points to violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Public companies and their executives must follow strict transparency rules under these provisions. Section 10(b) says no to “manipulative and deceptive practices” in securities trading. Section 20(a) means executives could be personally liable if they knowingly mislead investors.
These legal standards are the foundations of claims that Fortrea “made materially false and/or misleading statements”. The lawsuit says statements about 2025 EBITDA targets and TSA exit benefits “lacked reasonable basis”.
Public companies like Fortrea must follow stricter rules than private ones. They need to give accurate, timely information about anything that affects their financial future. This case shows companies need solid evidence before making any claims about cost savings, revenue growth, or profit targets.
Conclusion
The Fortrea Class Action Lawsuit serves as one of the most important warning signs for investors dealing with complex corporate spin-offs. This case expresses major gaps between what companies promise and what they deliver when they break away from their parent organizations. Market confidence can crumble quickly when basic business assumptions fail, as shown by the stock’s massive 45% drop across three major declines.
The lawsuit claims the company’s financial forecasts lacked solid foundation, especially when you have pre-spin projects, TSA exit cost savings, and EBITDA targets. These claims show why investors need to look more carefully at spin-off companies’ legacy contract revenue and transition costs. It also raises key questions about executive responsibility and the quality of statements made during these business changes.
Securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act set tough rules for what public companies must disclose. This legal fight could shape how future spin-offs tell investors about their financial outlook and business challenges. Investors who lost money still have options. Those who want to become lead plaintiff in the Fortrea Class Action Lawsuitor have questions about their shareholder rights can reach out to attorney Timothy L. Miles at the Law Offices of Timothy L. Miles. He offers free consultations at 855/846-6529 or [email protected].
We have a long way to go, but we can build on this progress through August 2025 and beyond. This case deserves close attention from both Fortrea shareholders and anyone invested in companies going through similar corporate restructuring. The final ruling could set new standards for transparency and executive accountability in corporate spin-offs.
Frequently Asked Questions About the Fortrea Lawsuit
Q1. What is the Fortrea class action lawsuit about? The lawsuit alleges that Fortrea Holdings made false and misleading statements about its business and financial prospects, including overstating revenue from pre-spin projects and inflating EBITDA targets for 2025.
Q2. Who is eligible to participate in the Fortrea lawsuit? Investors who purchased or acquired Fortrea securities between July 3, 2023 and February 28, 2025 may be eligible to join the class action lawsuit.
Q3. What are the key allegations against Fortrea executives? The lawsuit claims that Fortrea executives withheld key information about revenue shortfalls, misrepresented benefits of exiting transition service agreements, and made statements about financial targets that lacked reasonable basis.
Q4. How can investors join the Fortrea class action lawsuit? Eligible investors can join as class members without taking immediate action, or file to become lead plaintiffs by the August 1, 2025 deadline. There are no upfront legal fees to participate.
Q5. What impact did the allegations have on Fortrea’s stock price? Fortrea’s stock price experienced three major drops, including a 12% fall after a Jefferies downgrade, an 8% decline following a Baird downgrade, and a 25% crash after disappointing earnings were announced in March 2025.
Contact Timothy L. Miles Today About a Fortrea Class Action Lawsuit
If you suffered losses in Fortrea stock, call us today for a free case evaluation about an Fortrea Class Action Lawsuit. 855-846-6529 or [email protected] (24/7/365).
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com
